Representative before the EPO

Employment test 501 - 1000 employees
Company dna marks and clerk llp
operating since 1887
Headquarter in London and 16 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading

Donald C. McNab has worked on the following 82 EPO patent applications which have been published in the last five years:

EP11723104

CATIONIC LIPIDS

IPC classification:
C07C 233/18, C07K 5/068, C07K 5/09, C12N 15/88, A61K 47/48
Applicant:
The University Court of the University of Edinburgh
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11803066

1,2-BIS-(4,7-DIMETHYL-1,4,7-TRIAZACYCLONON-1-YL)-ETHANE AND INTERMEDIATE THEREOF

IPC classification:
C07D 255/02, C07D 403/06
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
PATENT GRANTED
EP10787527

SILICON PHOSPHATE AND MEMBRANE COMPRISING THE SAME

IPC classification:
B01D 69/14, C08F 259/08, C08J 5/22, C08K 3/32, C08K 3/34, H01M 8/02, H01M 8/10
Applicant:
The University Court of the University of St. Andrews
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP12700515

ANTISKINNING COMPOSITIONS

IPC classification:
C09D 7/04, C09D 167/08
Agent:
Abel & Imray
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP12704519

ADDITIVE METALLISATION PROCESS

IPC classification:
C23C 18/14
Applicant:
Heriot-Watt University
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12707186

CYTOTOXIC BENZODIAZEPINE DERIVATIVES AND METHODS OF PREPARATION

IPC classification:
A61P 35/00, C07D 487/04, C07D 519/00, A61K 47/48
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP11716290

BLEACHING OF SUBSTRATES

IPC classification:
B01J 31/18, C11D 3/39
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
The patent has been granted
EP12804785

FIBER MATS COATED WITH NANOGRID VISIBLE SPECTRUM PHOTOCATALYSTS

IPC classification:
D01F 6/00
Applicant:
The Research Foundation for The State University of New York
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12823601

METHOD AND COMPOSITION FOR IN SITU FORMATION OF AN ARTIFICIAL BLOCKAGE TO CONTROL BLOOD LOSS

IPC classification:
A61L 15/42
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP11871967

CATALYSTS

IPC classification:
C07F 13/00
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP12780273

METHOD FOR EFFECTING A PHOTOCATALYTIC OR PHOTOELECTROCATALYTIC REACTION

IPC classification:
B01J 23/20, B01J 35/00, C01B 3/04
Applicant:
The University Court of the University of St. Andrews
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP12802456

IMPLANT INSERTION DEVICE AND METHOD OF USE THEREOF

IPC classification:
A61B 17/02, A61B 17/34, A61F 2/12, A61M 1/00
Applicant:
University Hospitals Cleveland Medical Center
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
PATENT GRANTED
EP12806647

FLUORESCENT DYES BASED ON ACRIDINE AND ACRIDINIUM DERIVATIVES

IPC classification:
G01N 33/52, A61K 31/435
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP12796910

ORGANIC COMPOUNDS

IPC classification:
A61P 25/00, A61P 27/06, C07D 487/04, C07D 487/14, A61K 31/505, A61K 31/519
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP13820704

LONG CHAIN BASE SPHINGOSINE KINASE INHIBITORS

IPC classification:
A61K 31/155
Applicant:
University of Virginia Patent Foundation
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP12733317

OLIGOSACCHARIDE/SILICON-CONTAINING BLOCK COPOLYMERS FOR LITHOGRAPHY APPLICATIONS

IPC classification:
B82Y 40/00, C07H 3/06, C08F 293/00, C08G 73/06, C08G 81/02, G03F 7/00
Applicant:
The Board of Regents of the University of Texas System
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
APPLICATION WITHDRAWN
EP12796691

METHODS OF TREATING FIBROTIC DISEASES USING TETRAHYDROCANNABINOL-11-OIC ACIDS

IPC classification:
A61P 1/16, A61P 11/00, A61P 13/12, A61P 17/00, A61P 21/00, A61P 29/00, A61K 31/352
Agent:
Donald C. McNab, Marks & Clerk LLP
Agent:
Marion Chajmowicz, Cabinet Becker & AssociƩs
Status:
EXAMINATION REQUESTED
EP13776297

ORGANIC COMPOUNDS

IPC classification:
A61K 31/4985
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP13776208

NOVEL COMPOSITIONS AND METHODS

IPC classification:
A61K 31/4985
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP13778465

METHOD AND APPARATUS FOR USE IN THE TREATMENT OF WATER

IPC classification:
C02F 3/12, C02F 3/28, C02F 3/30, C02F 3/34, C02F 9/14
Applicant:
Nanyang Technological University
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP12719158

IN-SITU GEL FORMING COMPOSITIONS

IPC classification:
A61L 26/00, A61L 27/20, A61L 27/52
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
PATENT GRANTED
EP11738028

METHOD FOR THE OXIDATION OF UNSATURATED ORGANIC COMPOUNDS

IPC classification:
C07C 51/285, C07C 53/126, C07C 55/02, C07C 55/14, C07C 63/06
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13759049

CYTOTOXIC BENZODIAZEPINE DERIVATIVES

IPC classification:
A61K 47/48
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP13763278

METATHESIS REACTIONS WITH CARDANOL AND/OR ANACARDIC ACID

IPC classification:
C07C 1/20, C07C 11/02, C07C 11/12, C07C 11/21, C07C 37/00, C07C 37/50, C07C 39/06, C07C 39/19, C07C 41/03, C07C 43/23
Applicant:
The University Court of the University of St. Andrews
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP13774881

IMPROVED METHODS FOR THE ACYLATION OF MAYTANSINOL

IPC classification:
C07D 498/18
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP14192547

Semi-solid delivery vehicle and pharmaceutical compositions

IPC classification:
A61P 1/08, A61K 9/00, A61K 9/06, A61K 9/08, A61K 9/10, A61K 31/445, A61K 31/573, A61K 47/34
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14782493

INTRAVENOUS MEDICATION DELIVERY SYSTEM

IPC classification:
A61M 1/00
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11761110

POLYMERS, THEIR METHOD OF MANUFACTURE AND USE THEREOF

IPC classification:
C08G 69/00, C08G 69/40, C08G 73/02
Applicant:
The University Court of the University of Edinburgh
Applicant:
University College Cardiff Consultants Limited
Agent:
Simon David Haslam, Abel & Imray
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP11757925

POLYMERISATION METHOD

IPC classification:
C08G 12/08, C08G 12/26, C08G 73/00
Applicant:
The University Court of The University of Aberdeen
Applicant:
University College Cardiff Consultants Limited
Agent:
Simon David Haslam, Abel & Imray
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP13814394

PHARMACEUTICAL COMPOSITION COMPRISING ANTIEMETIC COMPOUNDS AND POLYORTHOESTER

IPC classification:
A61P 1/08, A61K 9/00, A61K 31/4178, A61K 31/439, A61K 31/5377, A61K 31/675, A61K 47/34
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
APPLICATION WITHDRAWN
EP15152132

Organic compounds

IPC classification:
A61P 9/10, A61P 15/00, A61P 25/00, A61K 31/519
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14701657

STABILIZED COMPOSITIONS COMPRISING HYALURONIC ACID

IPC classification:
C08L 5/08, A61K 31/728, A61K 47/36
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14710945

OXIDATIVELY CURABLE COATING COMPOSITION

IPC classification:
C09D 167/00
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP13874359

CELL THERAPY FOR THE TREATMENT OF NEURODEGENERATION

IPC classification:
C12N 5/00, C12N 5/071, A01N 63/00
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14703167

OXIDATIVELY CURABLE COATING COMPOSITION

IPC classification:
C09D 167/00
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP14710946

DRIER FOR ALKYD-BASED COATING

IPC classification:
C09D 167/00
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP12705600

CYTOTOXIC BENZODIAZEPINE DERIVATIVES

IPC classification:
A61P 35/00, C07D 487/04, C07D 519/00, A61K 47/48
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14767699

CLAY COMPOSITES AND THEIR APPLICATIONS

IPC classification:
A61L 15/18
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14769531

AN IMPROVED CHEMIRESISTOR SENSOR

IPC classification:
G01N 27/04, G01N 27/12
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP11740973

SALT AND SOLVATES OF A TETRAHYDROISOQUINOLINE DERIVATIVE

IPC classification:
C07D 217/26
Applicant:
Novartis AG
Agent:
Donald C. McNab, Marks & Clerk LLP
Agent:
Michael Stierwald, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14732322

BLEACH AND OXIDATION CATALYST

IPC classification:
B01J 21/16, B01J 31/18, B01J 31/22, B01J 31/26, C11D 3/16, C11D 3/39, C11D 17/00
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14737309

INOSITOL BIOTRANSFORMATION

IPC classification:
C07F 9/00, C12P 19/02
Applicant:
The University Court of the University of St. Andrews
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP10846825

PREPARATION OF BLEACHING CATALYSTS

IPC classification:
C07F 13/00
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11838805

CYTOTOXIC AGENTS COMPRISING NEW ANSAMITOCIN DERIVATIVES

IPC classification:
A61P 35/00, A61K 39/00, A61K 47/48
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15190436

IMPROVED CYTOTOXIC AGENTS COMPRISING NEW MAYTANSINOIDS

IPC classification:
C07D 491/12, C07D 498/16, A61K 31/5365, A61K 47/48
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14750798

COMPOSITION

IPC classification:
C11D 3/02, C11D 3/12, C11D 3/386, C11D 3/39, C11D 17/00
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP14838754

BRUTON'S TYROSINE KINASE AS ANTI-CANCER DRUG TARGET

IPC classification:
C07K 16/40, A61K 31/713, A61K 35/00
Applicant:
The Research Foundation for The State University of New York
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP11720566

FREENESS OF PAPER PRODUCTS

IPC classification:
D21C 9/00, D21C 9/10, D21C 9/16, D21D 1/02, D21D 1/20, D21D 1/30, D21D 1/34
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
PATENT GRANTED
EP14796581

ROTARY BELL CUP ATOMIZER HAVING IMPROVED CLEANING CAPABILITY

IPC classification:
B05B 3/10, B05B 13/04, B05B 15/02
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
The patent has been granted
EP14844848

COMPOSITE PIGMENTS

IPC classification:
B82Y 30/00, C08K 3/22, C08K 3/34, C09C 1/02, C09C 1/04, C09C 1/28, C09C 1/36, C09C 1/40, C09D 1/00
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP12705761

METHODS OF PREPARATION OF CONJUGATES

IPC classification:
A61P 35/00, C07D 487/04, C07D 519/00, A61K 47/48
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP16150802

CYTOTOXIC BENZODIAZEPINE DERIVATIVES

IPC classification:
A61P 35/00, C07D 487/04, C07D 519/00, A61K 47/48
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP12730230

METHOD OF LABELLING A BIOLOGICALLY ACTIVE MOLECULE WITH A 5-FLUORO-5-DEOXYPENTOSE OR A 3-FLUORO-3-DEOXYPENTOSE

IPC classification:
A61K 51/08
Applicant:
The University Court of the University of St. Andrews
Applicant:
University of Turku (Turun yliopisto)
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16155572

MODIFICATION OF THE PH AND OTHER PHYSICAL PROPERTIES OF OXALOACETIC ACID TO ALLOW FOR ENHANCED STABILITY

IPC classification:
A61K 9/20, A61K 31/194, A61K 47/02, A61K 47/12, A61K 47/14, A61K 47/26
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP11790279

ORGANIC COMPOUNDS

IPC classification:
C07D 471/04
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12195556

tether intermediates for the synthesis of macrocyclic ghrelin receptor modulators

IPC classification:
C07C 211/27, C07C 271/12, C07C 403/18, C07K 5/12
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
PATENT GRANTED
EP11790277

ORGANIC COMPOUNDS

IPC classification:
A61P 25/00, C07D 487/04, A61K 31/519
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP11846704

METHODS FOR THE PREPARATION OF CHARGED CROSSLINKERS

IPC classification:
C07D 207/452, C07D 207/46, C07D 213/71, C07D 401/12
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
PATENT GRANTED
EP14851616

A MEDICINAL COMPOSITION OF EXTRACT OF SEED OF EMBLICA OFFICINALIS AND METHOD OF PREPARING THE SAME

IPC classification:
A61K 36/00, A61K 36/47
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14860326

TARGETED TREATMENT OF ANEROBIC CANCER

IPC classification:
C12N 15/09
Applicant:
University Hospitals Cleveland Medical Center
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14867061

NOVEL METHODS

IPC classification:
C07D 241/36, A61K 31/437, A61K 31/4985
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP11742780

CD20 ANTIBODIES AND USES THEREOF

IPC classification:
A61P 35/00, C07K 16/28, C12P 21/08, A61K 39/395, A61K 47/48, A61K 51/10
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
PATENT GRANTED
EP14877044

POLYMER-BASED COMPOSITIONS FOR EXTENDED RELEASE OF PROTEINS

IPC classification:
A61K 9/52
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15735265

ORGANIC COMPOUNDS

IPC classification:
A61K 31/519
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15702837

COMPOSITION

IPC classification:
C09D 7/00
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15702552

SYNTHETIC METHOD

IPC classification:
C07C 11/02, C07C 37/00
Applicant:
The University Court of the University of St. Andrews
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14883985

URINALYSIS DEVICE AND DRY REAGENT FOR QUANTITATIVE URINALYSIS

IPC classification:
G01N 21/25, G01N 33/70
Applicant:
Nitto Denko Corporation
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP11700697

CURING LIQUIDS

IPC classification:
C08K 5/34, C08K 9/00
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15773031

ORGANIC COMPOUNDS

IPC classification:
C07D 471/14, A61K 31/4985
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15721334

POLYMORPHIC FORMS OF 4,5-DIHYDRO-1H-PYRROLO[2,3-F]QUINOLINE-2,7,9-TRICARBOXYLIC ACID AND ITS DISODIUM SALT, PROCESS FOR THEIR PREPARATION AND THEIR USE

IPC classification:
C07D 471/04, A61K 31/4745
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15780447

ALLENAMIDE AS AN ORTHOGONAL HANDLE FOR SELECTIVE MODIFICATION OF CYSTEINE IN PEPTIDES AND PROTEINS

IPC classification:
C07C 233/09, C07C 233/38, C07C 235/28, C07D 311/16, C07D 403/06, C07D 493/10
Applicant:
Nanyang Technological University
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15719954

COMPOSITIONS OF A POLYORTHOESTER AND AN ORGANIC ACID EXCIPIENT

IPC classification:
A61K 9/00, A61K 31/00, A61K 47/12, A61K 47/34
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP16186412

METHODS FOR THE PREPARATION OF CHARGED CROSSLINKERS

IPC classification:
C07D 207/452, C07D 207/46, C07D 213/71, C07D 401/12
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
Request for examination was made
EP15829416

ORGANIC COMPOUNDS

IPC classification:
C07D 487/14, A61K 31/519
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15763741

CYTOTOXIC BENZODIAZEPINE DERIVATIVES

IPC classification:
A61P 35/00, C07D 487/04, C07D 519/00, C07K 7/02, C07K 16/28, A61K 31/5513
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
Request for examination was made
EP15763739

CYTOTOXIC BENZODIAZEPINE DERIVATIVES

IPC classification:
A61P 35/00, C07D 487/04, C07D 519/00, C07K 7/02, C07K 16/28, A61K 31/5513
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
Request for examination was made
EP15838694

METHOD OF TREATING ORGANOPHOSPHATE INTOXICATION

IPC classification:
A61P 25/28, A61K 9/48, A61K 31/56
Applicant:
Texas A&M University System (TAMU)
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
Request for examination was made
EP15766288

CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS

IPC classification:
A61P 35/00, C07K 16/28, C07K 16/30, A61K 31/5517
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
Request for examination was made
EP15754074

COMPOSITE AIR BEARING ASSEMBLY

IPC classification:
B05B 3/04, B05B 7/02, F16C 32/06, F16C 35/02, F16C 43/02
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
Request for examination was made
EP15772163

EMULSON FORMULATIONS OF APREPITANT

IPC classification:
A61K 9/00, A61K 47/10, A61K 47/12, A61K 47/24, A61K 47/26, A61K 47/44
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
Request for examination was made
EP15854171

IMPROVED SINGLE MOLECULE PEPTIDE SEQUENCING

IPC classification:
G01N 33/68
Applicant:
The Board of Regents of the University of Texas System
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
Request for examination was made
EP15802310

PROCESS FOR PREPARING CELL-BINDING AGENT-CYTOTOXIC AGENT CONJUGATES

IPC classification:
A61K 47/50
Agent:
Donald C. McNab, Marks & Clerk LLP
Status:
Request for examination was made

Please Sign in to use this feature